FILING ANALYSIS · WEDNESDAY, OCTOBER 21
Elevance Health, Inc. ELV — 8-K: Results of Operations and Financial Condition
positive
Elevance Health, Inc. reported third quarter 2026 results ahead of expectations, with operating revenue of $50.4 billion and diluted EPS of $6.27, and raised its full-year guidance for diluted EPS to at least $22.00 and adjusted diluted EPS to at least $29.00.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →